6934 Stock Overview

Designs, develops, manufactures, and sells mesh nebulizers to deliver liquid medications into the respiratory airways. More details

6934 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap (NT$2B)

My Notes

Capture your thoughts, links and company narrative

HCmed Innovations Co., Ltd. Competitors

Crystalvue Medical

TPEX:6527

NT$2.2b

BenQ Medical Technology

TPEX:4116

NT$2.1b

Diamond Biotechnology

TPEX:6815

NT$2.3b

Applied BioCode

TWSE:6598

NT$2.5b

Price History & Performance

Summary of share price highs, lows and changes for HCmed Innovations
Historical stock prices
Current Share Price	NT$73.00
52 Week High	NT$93.30
52 Week Low	NT$64.70
Beta	0
1 Month Change	-1.08%
3 Month Change	-18.98%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	2.67%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	6934	TW Medical Equipment	TW Market
7D	-0.3%	2.1%	-1.3%
1Y	n/a	-5.4%	22.0%

Return vs Industry: Insufficient data to determine how 6934 performed against the TW Medical Equipment industry.

Return vs Market: Insufficient data to determine how 6934 performed against the TW Market.

Price Volatility

Is 6934's price volatile compared to industry and market?
6934 volatility
6934 Average Weekly Movement	3.8%
Medical Equipment Industry Average Movement	3.9%
Market Average Movement	4.4%
10% most volatile stocks in TW Market	8.0%
10% least volatile stocks in TW Market	2.1%

Stable Share Price: 6934 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 6934's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2014	n/a	Jason Cheng	www.hcmed-inno.com

HCmed Innovations Co., Ltd. designs, develops, manufactures, and sells mesh nebulizers to deliver liquid medications into the respiratory airways. The company’s products include Pulmogine, a vibrating mesh nebulizer to nebulize a range of liquid medications to treat respiratory diseases and their symptoms in children and adults; and AdheResp, a breath-actuated mesh nebulizer for consumers and healthcare professionals. It also provides contract development and manufacturing organization services.

HCmed Innovations Co., Ltd. Fundamentals Summary

How do HCmed Innovations's earnings and revenue compare to its market cap?
6934 fundamental statistics
Market cap	NT$2.19b
Earnings (TTM)	NT$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is 6934 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6934 income statement (TTM)
Revenue	NT$0
Cost of Revenue	NT$0
Gross Profit	NT$0
Other Expenses	NT$0
Earnings	NT$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did 6934 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/16 13:58
End of Day Share Price	2025/02/14 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

HCmed Innovations Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.